Comparative Affects of Circuit Training and Complex Training on Agility, Power and Core Strength.

NCT07440693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-02-27

No results posted yet for this study

Summary

Comparative Affects of Circuit Training and Complex Training on Agility, Power and Core Strength.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Moderate intensity Circuit training

Group A will engage in a circuit training protocol designed to enhance agility, power, and core strength over six weeks. Each session will commence with a 5-minute general warm-up to increase heart rate, followed by a static stretching routine targeting major muscle groups such as the hamstrings, quadriceps, and calves, with each stretch held for 15 to 20 seconds to improve flexibility and reduce the risk of injury.

OTHER

Moderate intensity Complex training

Group B will undergo complex training protocol aimed at enhancing agility, power, and core strength for six weeks. Each session starts with a 5-minute general warm-up, followed by a static stretching protocol to enhance muscle flexibility, covering key muscle groups like the quadriceps, hamstrings, glutes, and calves, with each stretch held for 15-20 seconds.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Ammar Hameed, MS SPT · Riphah International University

  • Maira Shaukat, DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-04
Primary Completion
2025-11-21
Completion
2025-12-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07440693 on ClinicalTrials.gov